Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

117.26 +1.33 (+1.15%)
Official Closing Price Updated: 7:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
40 41 Next >
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Berkshire Hathaway, Chipotle, More NYSE Stocks Hit With Trading Halts Triggered By Technical Issues
NYSE experiences trading halts Monday due to a technical issue. Stocks like Berkshire Hathaway and Chipotle are impacted. 
Via Benzinga
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
Vertex might not present a clear and present danger to Abbott and DexCom but could present a clear future threat. 
Via The Motley Fool
The 3 Best MedTech Stocks to Buy Now: May 2024
Explore the best MedTech stocks to buy now that are driven by AI's potential to revolutionize healthcare efficiency. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
These Dividend Stocks Are an Investor's Best Friend
These two healthcare stocks are well-known for their top-tier dividend programs. 
Via The Motley Fool
Looking At Abbott Laboratories's Recent Unusual Options Activity
Via Benzinga
How Is The Market Feeling About Abbott Laboratories?
Via Benzinga
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for May 2024
Investors would be wise to pay attention to the analyst ratings on these leading healthcare stocks to buy, which are expected to rise. 
Via InvestorPlace
Reliable Rewards: 7 Dividend Stocks to Count On in Any Market
With uncertainty clouding the market, investors can sleep a little easier at night with these reliable dividend stocks. 
Via InvestorPlace
Blue-Chip Bonanza: 3 Stocks to Ride the Market’s Coattails to Riches
The bull market momentum is unstoppable and these blue-chip stocks have the earnings growth to drive upside. 
Via InvestorPlace
8 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Critical Insights From Abbott Laboratories Analyst Ratings: What You Need To Know
Via Benzinga
What the Options Market Tells Us About Abbott Laboratories
Via Benzinga
Global Sports Nutrition Market Projected to Reach $78 Billion as Muscle Repair & Growth Becoming Vitally Important
EQNX::TICKER_START (OTCPK:MUSLF),(CSE:MUSL),(NYSE:ABT),(NASDAQ:CELH),(NASDAQ:MNST),(NYSE:BRBR) EQNX::TICKER_END 
Via FinancialNewsMedia
Jim Cramer Calls This Healthcare Stock A 'Worthy Spec,' Recommends Avoiding Canada Goose
Cramer recommends staying away from Canada Goose, even though it reported better-than-expected Q4 earnings. 
Via Benzinga
3 S&P 500 Stocks That Have Proven Themselves Recession-Proof
Corrections are a part of investing and investors would be smart to have these three S&P 500 stocks to buy when the inevitable happens. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Global Sports Nutrition Market Projected to Reach $78 Billion as Muscle Repair & Growth Becoming Vitally Important
From FN Media Group LLC
Via GlobeNewswire
Best Foundational Stocks
Building the foundation of investors portfolio with the best US foundational stocks by sector. 
Via Talk Markets
Catalyst's New CEO Has Big Ideas For The Small Biotech
Richard Daly is Catalyst Pharmaceuticals' second CEO, taking over for Patrick McEnany, who retired last year. 
Via Investor's Business Daily
Amazon, Abbott Laboratories And 2 Other Stocks Insiders Are Selling
Via Benzinga
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Check out these healthcare stocks for some healthy payouts. 
Via The Motley Fool
Stock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices Plunge
Investors should look for opportunities to buy these leading healthcare companies, each of which posted strong Q1 results. 
Via InvestorPlace
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
Via AB Newswire
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook. 
Via MarketBeat
7 Defensive Stocks Built to Withstand the Market’s Worst Storms
With the market operating under a worrisome backdrop, investors may want to target certain defensive stocks to buy. 
Via InvestorPlace
2 Beaten-Down Dividend Stocks to Buy and Hold Forever
These companies aren't in danger of becoming has-beens. 
Via The Motley Fool
Better Dividend Stock: AbbVie or Johnson & Johnson?
One thing is for sure: Dividend seekers can't go wrong with either. 
Via The Motley Fool
3 Dividend Stocks to Buy and Hold for the Next Decade
You'll get dividends and more with these great stocks. 
Via The Motley Fool
Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth
Intelligent Bio Solutions (Nasdaq: INBS) is a medical technology company developing and commercializing innovative, intelligent, rapid, noninvasive testing solutions. 
Via Talk Markets
Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes
It's not just enough for a company to pay a dividend, investors should look for dividend growth stocks that can continue to pay. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
40 41 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.